NDC 59762-1389-7 - Doxazosin mesylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59762-1389
- Requested NDC
- 59762-1389-7
- Package NDCs from labels
- 59762-1389-7
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2024-03-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxazosin mesylate - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2024-03-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59762-1389-7 | Doxazosin mesylate | 100 in 1 BOTTLE | TABLET | 100 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59762-1389 | DOXAZOSIN MESYLATE TABLET [MYLAN PHARMACEUTICALS INC.] | 1 | Current NDC, 1 package rows | 20250511_2e524986-7903-416f-b2b8-d27295103e75.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PROPYLPARABEN, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR, PARAFFINUM | Energique, Inc. | f3db63df-62a4-48d6-92e7-94e4a5701552 | 2024-12-20 | Warnings | 368GB5141J |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals,Inc. | 88efdfb0-710f-768a-e053-2995a90aede4 | 2024-12-17 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Zydus Lifesciences Limited | ac889877-133c-4448-af5a-d77b3cbfe878 | 2024-11-28 | 197625 197628 197626 197627 86P6PQK0MU | |
| Doxazosin | DOXAZOSIN MESYLATE | A-S Medication Solutions | 9b6170e7-814a-46ef-b068-cf3e6508d5e1 | 2024-10-21 | Warnings, Adverse reactions | 197628 86P6PQK0MU |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | Energique, Inc. | 87c92497-8a51-4977-87fe-e0b4c6bafb19 | 2024-09-27 | Warnings | 368GB5141J |
| Dairy Allergen Mix | ADENOSINUM TRIPHOSPHORICUM DINATRUM, BENZOICUM ACIDUM, CHOLINUM, CINNAMIC ACID, EUGENOL, FOLIC ACID, FORMALINUM, HISTAMINUM HYDROCHLORICUM, L-ASPARAGINE (MONOHYDRATE), LAC DEFLORATUM, LAC VACCINUM, MENADIONE, OOPHORINUM (SUIS), PETROSELINUM SATIVUM, PHENYL ISOTHIOCYANATE, QUERCETIN, RUTIN, SACCHARUM LACTIS, ILEUM (SUIS), JEJUNUM (SUIS), STOMACH (SUIS), COUMARINUM, FOLLICULINUM, GABA (GAMMA-AMINOBUTYRIC ACID), SARCOLACTICUM ACIDUM, LAC CANINUM, LAC FELINUM, LAC HUMANUM, PIPERINE, CALCAREA CARBONICA, | Deseret Biologicals, Inc. | e03d8463-287a-4509-a9f4-0ad38a98377c | 2024-09-11 | Warnings | J2B2A4N98G |
| Dairy Allergen Mix | ADENOSINUM TRIPHOSPHORICUM DINATRUM, BENZOICUM ACIDUM, CALCAREA CARBONICA, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CALCIUM CITRATE, CALCIUM GLUCONATE, CARBO VEGETABILIS, CHAMOMILLA, CHOLINUM, CINNAMIC ACID, COUMARINUM, EUGENOL, FOLIC ACID, FOLLICULINUM, FORMALINUM, GABA (GAMMA-AMINOBUTYRIC ACID), GAERTNER BACILLUS (BACH), HISTAMINUM HYDROCHLORICUM, ILEUM (SUIS), JEJUNUM (SUIS), L-ASPARAGINE (MONOHYDRATE), LAC CANINUM, LAC DEFLORATUM, LAC FELINUM, LAC HUMANUM, LAC VACCINUM, MENADIONE, | Deseret Biologicals, Inc. | e2bc26d2-1719-40c5-a6f9-8ff1f364c3cf | 2024-09-06 | Warnings | J2B2A4N98G |
| Doxazosin | DOXAZOSIN MESYLATE | Aurobindo Pharma Limited | 93f2d724-5a54-4721-b04a-e46bc764607b | 2024-09-06 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | 8c0c0345-833b-4a3d-9081-da66b208d750 | 2024-09-05 | Warnings, Adverse reactions | 197625 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | ef8b5534-5939-400a-ad5e-f9ceaefc4097 | 2024-09-05 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Bryant Ranch Prepack | ac4cd22b-2a03-47b6-9eed-550be278f17d | 2024-09-05 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Accord Healthcare Inc. | 2830533c-ccdf-4401-b19c-763eeb1bc0a7 | 2024-08-15 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 40e47e75-6a47-323b-e054-00144ff8d46c | 2024-08-14 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals, Inc. | 505d3c4c-5506-72cc-e054-00144ff88e88 | 2024-07-09 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 7991373e-8a62-47f9-b4fb-90573485af4e | 2024-07-04 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Rising Pharma Holdings, Inc. | 508b908e-8d80-422e-8ec0-2081185f4c95 | 2024-06-19 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 4034fb6d-f55d-4df0-b500-d6a413591f6e | 2024-06-12 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 9f67fa58-f623-4145-9e2c-98feee7ca45f | 2024-06-10 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | A-S Medication Solutions | 46b01b1d-c48a-4c36-bf3c-bba98066166c | 2024-06-10 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | NuCare Pharmaceuticals,Inc. | 64a243e6-7056-115d-e053-2a91aa0a510f | 2024-06-06 | Warnings, Adverse reactions | 197625 86P6PQK0MU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.